. is a biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world including endometriosis, anxiety, depression, pain, diabetes, irritable bowel syndrome, insomnia and other neurological and endocrine related diseases and disorders. Neurocrine Biosciences, Inc. news releases are available through the Company's website via the internet at http://www.neurocrine.com.

(Date:3/3/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/rcv4lq/gene_therapy ... Therapy Market, 2015 - 2025" report to their ... report provides an extensive study on the marketed and ... carried out in this field for over a decade ... in Asian markets; one approved in the EU). There ...

(Date:3/3/2015)... Clara, California (PRWEB) March 03, 2015 ... development service company, has launched a new Life Science ... reagents for preclinical research. , The first products ... antibody isotype controls, and soon to be released in ... company will continue to expand their life science portfolio ...

(Date:3/3/2015)... Md. , March 3, 2015 RegeneRx Biopharmaceuticals, ... editorial in the scientific journal, Expert Opinion on ... his colleague, Dr. Zhenggang Zhang , at the ... reported that Thymosin beta 4 (TB4) has the ... remodeling 24 hours or more post-injury, leading to neurological ...

(Date:3/3/2015)... Liberty Corner, New Jersey (PRWEB) March 03, 2015 ... in NJ, has announced today that it has ... DE. Terms of the transaction were not ... engineering consulting services to the energy sector including ... gas, alternative energy, and fossil and nuclear power ...

... Jim Slevin Joins from CV Therapeutics as Senior Director ... Management, Integrated Healthcare ... a medical,technology company committed to the development and commercialization ... hired Jim,Slevin to serve as the Senior Director of ...

... 8 Jazz,Pharmaceuticals, Inc. (Nasdaq: JAZZ ) announced today ... of Directors, effective,October 4, 2007. The Company also announced that ... October 3, 2007. Mr. Zilkha is a Principal at ... of the Health Care industry team. Prior to joining KKR,earlier ...

(Date:1/22/2015)... S.A. ("Company") (BM&FBOVESPA: VLID3 ON), is pleased to inform its ... of Washington,s Department of Licensing, in the United ... system for driver,s licenses and identification cards to its subsidiary, ... will start in January 2015, with enrollment and card production ...

... is giving the VIP treatment to laboratory mice in ... , VIP is not "very important person," but vasoactive ... gut, that is also made by a specialized group ... Washington University assistant professor of Biology in Arts & ...

... the genes, cancer is always rooted in genetic errors ... of the first genetic triggers for cancer as mutations ... and metastatic cancers, however, often exhibit many genetic mutations, ... question, and one with significant clinical implications, has been ...

... clones of cells from existing human embryonic stem cells. The ... and spinal cord injury. , "This cloning of cells involves ... extracting and then growing a single cell," said UNSW Senior ... is based at the Diabetes Transplant Unit (DTU) at the ...